-
公开(公告)号:US20230126400A1
公开(公告)日:2023-04-27
申请号:US17821006
申请日:2022-08-19
Applicant: Alector LLC
Inventor: Philip KONG , Herve RHINN , Tina SCHWABE , Angie YEE , Ilaria TASSI , Muhammad Abbas ALHAWAGRI , Arnon ROSENTHAL
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc.. that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20220348656A1
公开(公告)日:2022-11-03
申请号:US17836707
申请日:2022-06-09
Applicant: Alector LLC
Inventor: Tina SCHWABE , Michael KURNELLAS , Arnon ROSENTHAL , Robert PEJCHAL , Anthony B. COOPER
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20220251190A1
公开(公告)日:2022-08-11
申请号:US17459835
申请日:2021-08-27
Applicant: Alector LLC
Inventor: Kate MONROE , Helen LAM , Francesca AVOGADRI-CONNORS , Seung-Joo LEE , William MONTEITH , Herve RHINN , Arnon ROSENTHAL
IPC: C07K16/28 , A61P35/00 , A61K39/395 , C12N15/85
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210261685A1
公开(公告)日:2021-08-26
申请号:US17118921
申请日:2020-12-11
Applicant: Alector LLC
Inventor: Seung-Joo LEE , Spencer LIANG , Angie YEE , Marina ROELL , Arnon ROSENTHAL
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MerTK polypeptide, e.g., a mammalian MerTK or human MerTK, and use of such compositions in treating an individual in need thereof.
-
公开(公告)号:US20200339680A1
公开(公告)日:2020-10-29
申请号:US16959081
申请日:2018-12-21
Applicant: ALECTOR LLC
Inventor: Arnon ROSENTHAL , Eric BROWN , Tina SCHWABE , Angie YEE , Herve RHINN
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, antibody fragments, etc., that specifically bind a TMEM106B polypeptide, e.g., a mammalian TMEM106B or human TMEM106B, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20200277374A1
公开(公告)日:2020-09-03
申请号:US16792040
申请日:2020-02-14
Applicant: Alector LLC
Inventor: Kate MONROE , Helen LAM , Arnon ROSENTHAL , Seung-Joo LEE , Francesca AVOGADRI-CONNORS , William MONTEITH
IPC: C07K16/28 , A61K39/395 , A61K45/06
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20190233496A1
公开(公告)日:2019-08-01
申请号:US16121297
申请日:2018-09-04
Applicant: Alector LLC
Inventor: Arnon ROSENTHAL
IPC: C07K14/725 , C07K14/715 , C12N5/00 , A61P25/28 , C07K14/47 , C07K16/18 , C07K14/705 , A61K39/00
CPC classification number: C07K14/7051 , A01K2227/105 , A01K2267/0312 , A61K35/15 , A61K38/00 , A61K39/0007 , A61K48/00 , A61K48/005 , A61K2039/5154 , A61K2039/5156 , A61P25/28 , C07K14/4711 , C07K14/70517 , C07K14/7153 , C07K16/18 , C07K2317/622 , C07K2319/02 , C07K2319/03 , C07K2319/33 , C12N5/00 , C12N2740/16043
Abstract: The present disclosure is related to compositions that include polynucleotides encoding chimeric receptors, methods of delivering polynucleotides encoding chimeric receptors to immune cells, and methods of using immune cells encoding chimeric receptors to treat or prevent a neurological disease, disorder, or injury.
-
公开(公告)号:US20190127475A1
公开(公告)日:2019-05-02
申请号:US15999627
申请日:2018-08-20
Applicant: Alector LLC
Inventor: Arnon ROSENTHAL , Tina SCHWABE , Michael KURNELLAS
IPC: C07K16/28 , A61K31/7088
CPC classification number: C07K16/2863 , A61K31/7088 , C07K16/286 , C07K2317/14 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/76 , C07K2317/92 , C07K2319/30 , C07K2319/32
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20190085076A1
公开(公告)日:2019-03-21
申请号:US15735946
申请日:2016-06-11
Applicant: ALECTOR LLC
Inventor: Arnon ROSENTHAL , Kate MONROE , Francesca AVOGADRI-CONNORS
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20180265586A1
公开(公告)日:2018-09-20
申请号:US15867609
申请日:2018-01-10
Applicant: ALECTOR LLC
Inventor: Arnon ROSENTHAL , Tina SCHWABE , Michael KURNELLAS , Robert PEJCHAL , Anthony B. COOPER
IPC: C07K16/28
CPC classification number: C07K16/2863 , A61K31/7088 , C07K16/286 , C07K2317/14 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/76 , C07K2317/92 , C07K2319/30 , C07K2319/32
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.
-
-
-
-
-
-
-
-
-